How To Reduce Compliance Risk In Packaging & Labeling

By Arpad Lehoczki and Jonathan Hou, Director of Technology; Global Vision Systems

There is no such thing as a small print error on pharmaceutical drug labels or packaging. One missing dot or dash can be harmful to consumers and result in substantial recall costs for the pharma company. Inadequate manual inspection processes are to blame for print errors. These labor-intensive proofreading marathons are only as foolproof as humans themselves. But manual inspections are also concerning for a lesser-known reason — they may not comply with new data-integrity standards. What can you do to reduce your compliance risk?